Company Description
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Europe, the Middle East, Africa, the Asia Pacific, and internationally.
The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EVO, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead.
It also offers EksoCare offering an extended warranty and premium service options, repairs and maintenance services, and training programs.
Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.
| Country | United States |
| Founded | 2005 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 66 |
| CEO | Scott Davis |
Contact Details
Address: 101 Glacier Point, Suite A San Rafael, California 94901 United States | |
| Phone | 510 984 1761 |
| Website | eksobionics.com |
Stock Details
| Ticker Symbol | EKSO |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001549084 |
| CUSIP Number | 282644301 |
| ISIN Number | US2826443010 |
| SIC Code | 3569 |
Key Executives
| Name | Position |
|---|---|
| Scott G. Davis | Chief Executive Officer and Director |
| Jerome Wong | Chief Financial Officer and Corporate Secretary |
| Jason C. Jones | Chief Operating Officer |
| Rachael Anderson | Global Director of Marketing and Strategic Growth |
| Ann Cookson | Human Resources Director |
| Foon Lim Chwee | President of APAC |
| Stephan Aderhold | Senior Vice President and GM of EMEA |
| Katherine Strausser | Principal Controls Engineer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 18, 2025 | 11-K | Annual report of employee stock purchase, savings and similar plans |
| Apr 17, 2025 | EFFECT | Notice of Effectiveness |
| Apr 10, 2025 | S-3 | Registration statement under Securities Act of 1933 |
| Apr 10, 2025 | DEF 14A | Other definitive proxy statements |
| Mar 31, 2025 | PRE 14A | Other preliminary proxy statements |
| Mar 17, 2025 | 8-K | Current Report |
| Mar 3, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Mar 3, 2025 | 10-K | Annual Report |
| Mar 3, 2025 | 8-K | Current Report |
| Feb 14, 2025 | SCHEDULE 13G/A | Filing |